Liminatus Pharma Surges Over 5% After Announcing $500M BNB Investment Strategy
View all comments(0)
TradingKey – On Monday, July 28, Nasdaq-listed Liminatus Pharma Inc. (LIMN) jumped 5.28% in pre-market trading after unveiling plans to launch a dedicated crypto subsidiary focused on Binance Coin (BNB).

Liminatus Pharma Stock Chart – Source: Google
Liminatus, a preclinical-stage cancer immunotherapy company, announced it will form a new subsidiary called “American BNB Strategy” to manage and invest in BNB, the native token of the Binance ecosystem.
- The company aims to raise up to $500 million, deploying funds in phased investments targeting long-term BNB accumulation
- This move positions Liminatus alongside other corporate BNB holders like Nano Labs (NA), which currently holds 128,000 BNB
Coincidentally, the price of BNB soared above $850 today, setting a new record high. In the past 24 hours, BNB rose by more than 6%, reaching a high of $859 and temporarily reported at $849.

BNB price chart (1 hour), source: TradingView
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cryptos Decline Broadly, XRP Plunges Over 10% as CLARITY Act Fails to Pass US Senate

Meta launches new Meta One subscription tier to better monetize AI

US Stocks Fall, Dow Drops Over 300 Points as 10-Year Treasury Yield Surges to Nearly 19-Year High; Chip Stocks Buck Trend, SpaceX Drops Over 3%

Google Stock Price Forecast: Bucks Trend With Three-Day Rally, Shares Poised to Challenge $380 Again

Crude Oil Price Forecast: Brent Nears $110 Amid Saudi Pipeline Outage, How Much Further Can Oil Rise?







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.